← Leaderboards
Ann Marie Gregus
Virginia Polytechnic Inst And St Univ
$1,747,020
Attributed
$1,747,020
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $353.1K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,747,020 · 1
By mechanism
R01$1,747,020 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Polytechnic Inst And St Univ
Same institution · by research overlap
- Michael Klemba$2,121,739
- Yasuhiro Suzuki$11,960,130
- Igor V Sharakhov$3,395,556
- Lina Ni$2,111,990
Others in their field
Other Emerging Leaders on “Cell Type”
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Thomas Denny · Duke University$19,381,749
- Tomasz Nowakowski · University Of California, San Francisco$18,472,946
- Hemali Phatnani · New York University School Of Medicine$18,358,586
- Rui M. Costa · Columbia University Health Sciences$13,762,381
Research focus
Cell TypeCentral SensitizationBody TemperatureCellsBuprenorphineAcuteAgonistAddictionAllodyniaAnxietyAnalgesicsArachidonate 15-LipoxygenaseAffectiveArthralgiaArthritic PainArthritisAttenuatedAutoimmune DiseasesAntiepileptic AgentsBehavioralBehavior AssessmentBiochemicalApplications GrantsChronic
Grant awards (5)
15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis$352,000
R01 · FY2023 · AR · contact PI
15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis$348,480
R01 · FY2022 · AR · contact PI
15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis$341,440
R01 · FY2021 · AR · contact PI
15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis$352,000
R01 · FY2020 · AR · contact PI
15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis$353,100
R01 · FY2019 · AR · contact PI